You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SRAS-CoV-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Trial in Strasbourg (SRAS-CoV-2 vaccination immunological response)

Recruiting
  • Systemic Lupus
  • SRAS-CoV-2 vaccination immunological response
  • Strasbourg, Bas-Rhin, France
    University Hospital of Hautepierre
Aug 17, 2022

Coronavirus Infection Trial in Angers (revised HOME-CoV score)

Completed
  • Coronavirus Infection
  • revised HOME-CoV score
  • Angers, France
    CHU Angers
Mar 12, 2021

The Geneva Covid-19 CVD Study

Completed
  • COVID
  • CVD
  • Covid-19 + patients
  • Geneva, Switzerland
    Geneva University Hospital (HUG)
Oct 18, 2021

Coronavirus Trial in France (NG test, Blood test, Self-questionnary)

Completed
  • Coronavirus
  • NG test
  • +2 more
  • La Guerche de Bretagne, La Guerche-de-Bretagne, France
  • +8 more
Apr 13, 2021

COVID-19 in People Living With HIV

Unknown status
  • Adult Patients Living With HIV (PLWHIV) With Confirmed Infection With SARS-CoV-2 Since 1st January 2020
  • Biological collection (patients co infected HIV Sras-CoV-2)
  • +2 more
  • Le Kremlin-Bicêtre, France
    Department of Internal Medicine and Clinical Immunology of Profe
Apr 23, 2020

COVID-19 Trial (LYB001, Placebo)

Not yet recruiting
  • COVID-19
  • LYB001
  • Placebo
  • (no location specified)
Nov 25, 2021

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

Completed
  • SARS-CoV-2 Virus
  • SARS-CoV-2 RNA detection
  • Bangkok, Thailand
    2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

Recruiting
  • SARS-CoV2 Infection
  • General SARS-CoV-2 Communication
  • Rural-Targeted SARS-CoV-2 Communication
  • Flint, Michigan
    Flint Journal Building
Oct 10, 2023

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
  • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
  • (no location specified)
Aug 4, 2023

SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

Not yet recruiting
  • SARS-CoV-2 Infection
  • +2 more
  • eBAM Cov Testing
  • Marseille, France
  • +1 more
Oct 23, 2023

LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

Not yet recruiting
  • SARS-CoV-2
  • +4 more
  • LumiraDx SARS-CoV-2 Ag Ultra
  • LumiraDx SARS-CoV-2 & Flu A/B
  • DeLand, Florida
    Hillcrest Medical Research
Feb 6, 2023

SARS-CoV-2 Vaccination on Cancer Patients Infected With

Recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine
  • no intervention
  • Beijing, Beijing, China
    Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023

SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
  • 0.9% sodium chloride solution
  • Islamabad, Pakistan
    Sindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

Not yet recruiting
  • COVID-19 Vaccine
  • COVID-19
  • 50 μg Baiya SARS-CoV-2 Vax 2
  • Placebo
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
May 23, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in

Active, not recruiting
  • SARS-CoV-2 RNA Vaccines
  • HIV Infection
  • SARS-CoV-2 Vaccine
  • Sevilla, Spain
    Virgen del Rocio University Hospital
Dec 1, 2022

Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)

Completed
  • Sars-CoV-2 Infection
  • Bloemfontein, Free State, South Africa
  • +7 more
May 2, 2023

SARS-CoV-2 Infection Trial in Germany, United States (PRIME-2-CoV_Beta)

Recruiting
  • SARS-CoV-2 Infection
  • Florida City, Florida
  • +6 more
Jan 31, 2023

COVID-19 Transmission and Morbidity in Malawi

Recruiting
  • SARS CoV 2 Infection
  • SARS CoV 2 Vaccination
    • Boston, Massachusetts
    • +1 more
    Aug 6, 2023

    COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

    Completed
    • COVID-19
    • SARS-CoV-2 Infection
    • Quantitative analysis of SARS-CoV-2 antibodies
    • Cellular immunity
    • Prague, Czechia
      Institute of Health Information and Statistics of the Czech Repu
    Nov 25, 2022